Friday, July 10, 2026

Drug profile · INN

acetrizoate sodium

acetrizoate sodium (SALPIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrauterine. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — acetrizoate sodium
US status
approved
Class
Route
INTRAUTERINE
Patents
0
Programs
0
Data quality
0.84

Quick answer

acetrizoate sodium (SALPIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrauterine. Current US regulatory status: approved.

Key facts

INN acetrizoate sodium
Brand SALPIX
Route INTRAUTERINE
Formulation SOLUTION

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is acetrizoate sodium?

acetrizoate sodium (SALPIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrauterine. Current US regulatory status: approved.

What is the brand name for acetrizoate sodium?

SALPIX is a marketed brand name for acetrizoate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of acetrizoate sodium?

acetrizoate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.